Amla Gold 500 mg
Withdrawn from the US market on 9 September 2024 (according to the DSLD)
NutriGold, food supplement from the US market
Label withdrawn from the US market. Amla Gold 500 mg (NutriGold), a food supplement au code-barres 859447002395, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- NutriGold
- Barcode
- 859447002395
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Pullulan Capsule, Rice Concentrate
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin C | Vitamin | 45 mg |
| Amla Extract (Phyllanthus emblica) | Plant | 500 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Amla Gold 500 mg
Entered into DSLD on 27 July 2021. Withdrawn from the US market on 4 February 2022 (according to the DSLD).- Same quantity, different name: organic Amla extract in this version; Amla Extract on the displayed label (500 mg)
- Different quantity per serving : Vitamin C: 50 mg in this version; 45 mg on the displayed label
Official label: Amla Gold 500 mg
Entered into DSLD on 23 April 2020. Withdrawn from the US market on 19 March 2021 (according to the DSLD).- Same quantity, different name: organic Amla extract in this version; Amla Extract on the displayed label (500 mg)
- Different quantity per serving : Vitamin C: 50 mg in this version; 45 mg on the displayed label
Official label: Amla Gold 500 mg
Entered into DSLD on 24 July 2015. Withdrawn from the US market on 25 November 2019 (according to the DSLD).- Active ingredient added : organic Vitamin C (50 mg)
- Active ingredient removed : Vitamin C (45 mg)
- Same quantity, different name: organic Amla extract in this version; Amla Extract on the displayed label (500 mg)
Official label: Amla Gold 500 mg
Entered into DSLD on 27 October 2014. Withdrawn from the US market on 23 June 2015 (according to the DSLD).- Active ingredient added : organic Vitamin C (50 mg)
- Active ingredient removed : Vitamin C (45 mg)
- Same quantity, different name: organic Amla extract in this version; Amla Extract on the displayed label (500 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Amla Extract
Read the warning, when it applies and the studies cited
Amla - Phyllanthus Emblica
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Applies to products providing more than 3 grams of amla, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Condition of application: Amlapitta, Digestive tonic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Laxative.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).
Sources cited by Health Canada (3)
- CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
- Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.
Contraindications
Condition of application: Laxative.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Known adverse reactions
Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.
When using this product you may experience a laxative effect.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : NutriGold
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Amla Gold 500 mg : étiquette retirée du marché américain (NutriGold): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/859447002395-amla-gold-500-mg-nutrigold, updated 9 September 2024.